by jlohrconsulting | Jul 14, 2025 | Uncategorized
Monaldi Arch Chest Dis. 2025 Jul 10. doi: 10.4081/monaldi.2025.3425. Online ahead of print. ABSTRACT Globally, cardiovascular diseases (CVDs) are the major leading cause of death. Medical literature shows an association between CVDs and depressive symptoms, anxiety,...
by jlohrconsulting | Jul 14, 2025 | Uncategorized
Arthritis Care Res (Hoboken). 2025 Jul 14. doi: 10.1002/acr.25612. Online ahead of print. ABSTRACT This review summarizes AI-supported non-pharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current...
by jlohrconsulting | Jul 14, 2025 | Uncategorized
Clin Geriatr Med. 2025 Aug;41(3):307-327. doi: 10.1016/j.cger.2025.04.004. Epub 2025 May 23. ABSTRACT This scoping review examines the psychological implications of social isolation and loneliness (SIL) in older adults, emphasizing risk and resilience factors. SIL is...
by jlohrconsulting | Jul 14, 2025 | Uncategorized
Int Psychogeriatr. 2025 Jul 12:100113. doi: 10.1016/j.inpsyc.2025.100113. Online ahead of print. ABSTRACT OBJECTIVE: Studies have found elevation in a key biomarker of aging (the senescence-associated secretory phenotype (SASP) index) in depression. We investigated...
by jlohrconsulting | Jul 14, 2025 | Uncategorized
BMC Neurosci. 2025 Jul 13;26(1):40. doi: 10.1186/s12868-025-00964-6. ABSTRACT AIM: To explore the effects of arabinoxylan on the BDNF/TrkB/p-CREB signaling pathway in the prefrontal cortex of post-stroke depressed rats, and to explore its neuronal protective effects...
Recent Comments